Details of the Drug

General Information of Drug (ID: DMGNC6T)

Drug Name
M-0011
Synonyms N-0011; RhLAMAN, Zymenex; Recombinant human alpha-mannosidase (alpha mannosidosis), Zymenex
Indication
Disease Entry ICD 11 Status REF
Alpha-mannosidosis 5C56.21 Phase 3 [1]
Cross-matching ID
TTD ID
D06SVC

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Alpha-mannosidase (MANA) TTT2KE3 MA2B1_HUMAN ; MA2B2_HUMAN ; MA2C1_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01908712) Lamazym Aftercare Study FR. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01681953) A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis. U.S. National Institutes of Health.